Systematic transcriptome analysis reveals tumor-specific isoforms for ovarian cancer diagnosis and therapy

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 23, 2015, Pages E3050-E3057

  Barrett, Christian L ^a,b   DeBoever, Christopher ^a,c   Jepsen, Kristen ^c   Saenz, Cheryl C ^d   Carson, Dennis A ^a,c,d   Frazer, Kelly A ^a,b,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Bioinformatics; Diagnostics; Ovarian cancer; RNA seq; Therapeutics

Indexed keywords

LIPOLYSIS STIMULATED LIPOPROTEIN RECEPTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; PARATHYROID HORMONE RECEPTOR 2; PROTEIN; PROTEIN ETV4; PROTEIN FGFRL1; PROTEIN FOXM1; PROTEIN LSR; PROTEIN RAB11FIP4; RNA ISOFORM; TETRASPANIN; TRANSCRIPTOME; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BIOINFORMATICS; CANCER DIAGNOSIS; CANCER STEM CELL; CANCER THERAPY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; FEMALE; GENETICS; HIGH THROUGHPUT SEQUENCING; OVARIAN NEOPLASMS; REAL TIME POLYMERASE CHAIN REACTION;

FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; OVARIAN NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84931269218     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1508057112     Document Type: Article

References (61)

1. Farhangfar CJ, Meric-Bernstam F, Mendelsohn J, Mills GB, Lucio-Eterovic AK (2013) The impact of tumor heterogeneity on patient treatment decisions. Clin Chem 59(1):38-40.
2. Swanton C (2012) Intratumor heterogeneity: Evolution through space and time. Cancer Res 72(19):4875-4882.
3. Marusyk A, Almendro V, Polyak K (2012) Intra-tumour heterogeneity: A looking glass for cancer? Nat Rev Cancer 12(5):323-334.
4. Adamia S, et al. (2014) A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets. Clin Cancer Res 20(5):1135-1145.
5. Lupetti R, et al. (1998) Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage. J Exp Med 188(6):1005-1016.
6. Rousseaux S, et al. (2013) Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers. Sci Transl Med 5(186):186ra66-186ra66.
7. Coulie PG, Van den Eynde BJ, van der Bruggen P, Boon T (2014) Tumour antigens recognized by T lymphocytes: At the core of cancer immunotherapy. Nat Rev Cancer 14(2):135-146.
8. David CJ, Manley JL (2010) Alternative pre-mRNA splicing regulation in cancer: Pathways and programs unhinged. Genes Dev 24(21):2343-2364.
9. Venables JP, et al. (2009) Cancer-associated regulation of alternative splicing. Nat Struct Mol Biol 16(6):670-676.
10. Annala MJ, Parker BC, Zhang W, Nykter M (2013) Fusion genes and their discovery using high throughput sequencing. Cancer Lett 340(2):192-200.
11. Lonsdale J, et al.; GTEx Consortium (2013) The Genotype-Tissue Expression (GTEx) project. Nat Genet 45(6):580-585.
12. Mercer TR, et al. (2012) Targeted RNA sequencing reveals the deep complexity of the human transcriptome. Nat Biotechnol 30(1):99-104.
13. Wu P-Y, Phan JH, Wang MD (2013) Assessing the impact of human genome annotation choice on RNA-seq expression estimates. BMC Bioinformatics 14(Suppl 11):S8.
14. Chvatal VA (1979) A greedy heuristic for the set-covering problem. Math Oper Res 4(3):233-235.
15. Weatheritt RJ, Gibson TJ (2012) Linear motifs: Lost in (pre)translation. Trends Biochem Sci 37(8):333-341.
16. Oh S, Shin S, Janknecht R (2012) ETV1, 4 and 5: An oncogenic subfamily of ETS transcription factors. Biochim Biophys Acta 1826(1):1-12.
17. Teh M-T (2012) FOXM1 coming of age: Time for translation into clinical benefits? Front Oncol 2:146.
18. Lam AKY, et al. (2013) FOXM1b, which is present at elevated levels in cancer cells, has a greater transforming potential than FOXM1c. Front Oncol 3:11.
19. Hemler ME (2014) Tetraspanin proteins promote multiple cancer stages. Nat Rev Cancer 14(1):49-60.
20. Zhao W, Ji X, Zhang F, Li L, Ma L (2012) Embryonic stem cell markers. Molecules 17(6): 6196-6236.
21. Hwang JR, et al. (2012) Upregulation of CD9 in ovarian cancer is related to the induction of TNF-α gene expression and constitutive NF-κB activation. Carcinogenesis 33(1):77-83.
22. Leth-Larsen R, et al. (2012) Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis. Mol Med 18:1109-1121.
23. Reaves DK, et al. (2014) The role of lipolysis stimulated lipoprotein receptor in breast cancer and directing breast cancer cell behavior. PLoS ONE 9(3):e91747.
24. Cancer Genome Atlas Network (2012) Comprehensive molecular portraits of human breast tumours. Nature 490(7418):61-70.
25. Kinde I, et al. (2013) Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers. Sci Transl Med 5(167):167ra4.
26. Lee Y, et al. (2007) A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 211(1):26-35.
27. O'Shannessy DJ, et al. (2013) Gene expression analyses support fallopian tube epithelium as the cell of origin of epithelial ovarian cancer. Int J Mol Sci 14(7): 13687-13703.
28. Kim J, et al. (2012) High-grade serous ovarian cancer arises from fallopian tube in a mouse model. Proc Natl Acad Sci USA 109(10):3921-3926.
29. Kessler M, Fotopoulou C, Meyer T (2013) The molecular fingerprint of high grade serous ovarian cancer reflects its fallopian tube origin. Int J Mol Sci 14(4):6571-6596.
30. Marquez RT, et al. (2005) Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res 11(17):6116-6126.
31. Sproul D, et al. (2012) Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns. Genome Biol 13(10):R84.
32. Ge X, et al. (2005) Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 86(2):127-141.
33. Dobolyi A, Dimitrov E, Palkovits M, Usdin TB (2012) The neuroendocrine functions of the parathyroid hormone 2 receptor. Front Endocrinol (Lausanne) 3:121.
34. Nielsen M, et al. (2007) NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS ONE 2(8):e796.
35. Fritsch EF, et al. (2014) HLA-binding properties of tumor neoepitopes in humans. Cancer Immunol Res, 10.1158/2326-6066.CIR-13-0227.
36. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR (2011) Allele frequency net: A database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 39(Database issue):D913-D919.
37. Reva B, Antipin Y, Sander C (2011) Predicting the functional impact of protein mutations: Application to cancer genomics. Nucleic Acids Res 39(17):e118.
38. Zangi L, et al. (2013) Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. Nat Biotechnol 31(10): 898-907.
39. Zhou J, Shum K-T, Burnett JC, Rossi JJ (2013) Nanoparticle-based delivery of RNAi therapeutics: Progress and challenges. Pharmaceuticals (Basel) 6(1):85-107.
40. Lin Y, et al. (2012) An in-depth map of polyadenylation sites in cancer. Nucleic Acids Res 40(17):8460-8471.
41. Howald C, et al. (2012) Combining RT-PCR-seq and RNA-seq to catalog all genic elements encoded in the human genome. Genome Res 22(9):1698-1710.
42. Cancer Genome Atlas Research Network (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474(7353):609-615.
43. Tothill RW, et al.; Australian Ovarian Cancer Study Group (2008) Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res 14(16):5198-5208.
44. Verhaak RGW, et al.; Cancer Genome Atlas Research Network (2013) Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. J Clin Invest 123(1): 517-525.
45. Bustin SA, et al. (2009) The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55(4):611-622.
46. Mailman MD, et al. (2007) The NCBI dbGaP database of genotypes and phenotypes. Nat Genet 39(10):1181-1186.
47. Thierry-Mieg D, Thierry-Mieg J (2006) Ace View: A comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7(Suppl 1):S12.1-S12.14.
48. Pruitt KD, Tatusova T, Maglott DR (2007) NCBI reference sequences (RefSeq): A curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 35(Database issue):D61-D65.
49. Hsu F, et al. (2006) The UCSC known genes. Bioinformatics 22(9):1036-1046.
50. Harrow J, et al. (2012) GENCODE: The reference human genome annotation for The ENCODE Project. Genome Res 22(9):1760-1774.
51. Yamasaki C, et al.; Genome Information Integration Project And H-Invitational 2 (2008) The H-Invitational Database (H-InvDB), a comprehensive annotation resource for human genes and transcripts. Nucleic Acids Res 36(Database issue):D793-D799.
52. Trapnell C, et al. (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28(5):511-515.
53. Dobin A, et al. (2012) STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29(1): 15-21.
54. Cormen TH, Leiserson CE, Rivest RL, Stein C (2001) Introduction to Algorithms (MIT Press, Cambridge, MA).
55. Roberts A, Pachter L (2013) Streaming fragment assignment for real-time analysis of sequencing experiments. Nat Methods 10(1):71-73.
56. Untergasser A, et al. (2012) Primer3-new capabilities and interfaces. Nucleic Acids Res 40(15):e115.
57. Qu W, et al. (2012) MFEprimer-2.0: A fast thermodynamics-based program for checking PCR primer specificity. Nucleic Acids Res 40(Web Server issue):W205-W208.
58. Dwight Z, Palais R, Wittwer CT (2011) uMELT: Prediction of high-resolution melting curves and dynamic melting profiles of PCR products in a rich web application. Bioinformatics 27(7):1019-1020.
59. Savitzky A, Golay MJE (1964) Smoothing and differentiation of data by simplified least squares procedures. Anal Chem 36(8):1627-1639.
60. Rao X, Lai D, Huang X (2013) A new method for quantitative real-time polymerase chain reaction data analysis. J Comput Biol 20(9):703-711.
61. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8(2):R19.